Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 129Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Hematologic Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 65Leukemia 53Myelodysplastic Syndromes 49Lymphoma 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Lymphoma, Non-Hodgkin 29Multiple Myeloma 21Burkitt Lymphoma 21Leukemia, Myelomonocytic, Chronic 20Recurrence 18Neoplasms 18Lymphoma, Large B-Cell, Diffuse 15Leukemia, B-Cell 14Hodgkin Disease 14Myeloproliferative Disorders 13Lymphoma, Mantle-Cell 12Leukemia, Biphenotypic, Acute 12Lymphoma, Follicular 11Lymphoma, B-Cell 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell, Marginal Zone 10Anemia, Refractory, with Excess of Blasts 10Blast Crisis 8Primary Myelofibrosis 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic-Myeloproliferative Diseases 6

Interventions

zegocractin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatitis × Other hematologic neoplasm × 30 days × Clear all
NCT04195347 2026-06-03

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Pancreatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡